Home›Search›Human Psychopharmacology

Human Psychopharmacology

John Wiley and Sons Ltd · United Kingdom · Est. 1986

ISSN1099-1077

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (2 more)+12

Total90

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

151

days submission → published

measured · last 14 articles · accept 133d

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.662

H-Indexi

102

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.589

Total Worksi

3,580

Total Citationsi

66,222

2yr Mean Citednessi

0.92

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

Human Psychopharmacology: Clinical and Experimental is a psychopharmacology journal that publishes clinical and experimental research on new and established psychotropic medicines. It considers experimental studies of centrally active drugs, including herbal products, in clinical, social, and psychological contexts, as well as papers on drugs of abuse and drug dependency. The journal also welcomes animal studies relevant to human psychopharmacology.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1986

Annual Volume~ 35 articles / year

StatusActive (last: 2026)

Total Publications3,580

Publisher OrgWiley

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

John Wiley and Sons Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1099-1077

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

463

2019

688

2020

484

2021

265

2022

131

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Neurology (clinical)Q2

Pharmacology (medical)Q2

Psychiatry and Mental HealthQ2

NeurologyQ3

Subject Classification

Web of Science Categories

Clinical NeurologyPharmacology & PharmacyPsychiatryPsychology

Scopus Categories

Pharmacology (medical)Neurology (clinical)Psychiatry and Mental HealthNeurology

Research Topics (OpenAlex)

Treatment of Major DepressionSchizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorAttention Deficit Hyperactivity DisorderAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesBipolar Disorder and TreatmentTryptophan and brain disordersElectroconvulsive Therapy StudiesForensic Toxicology and Drug AnalysisSleep and related disorders

Frequently asked questions about Human Psychopharmacology

Is Human Psychopharmacology a predatory journal?

PubScope has no integrity flags on record for Human Psychopharmacology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Human Psychopharmacology?

Human Psychopharmacology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.92.

Is Human Psychopharmacology indexed in Scopus and Web of Science?

Human Psychopharmacology is indexed in Web of Science, Scopus.